|
1.
|
Hua J, Suguro S, Hirano S, Sakamoto K and
Nagaoka I: Preventive actions of a high dose of glucosamine on
adjuvant arthritis in rats. Inflamm Res. 54:127–132. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Reginster JY, Deroisy R, Rovati LC, Lee
RL, Lejeune E, Bruyere O, Giacovelli G, Henrotin Y, Dacre JE and
Gossett C: Long-term effects of glucosamine sulphate on
osteoarthritis progression: a randomized, placebo-controlled
clinical trial. Lancet. 357:251–256. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Largo R, Alvarez-Soria MA, Diez-Ortego I,
Calvo E, Sanchez-Pernaute O, Egido J and Herrero-Beaumont G:
Glucosamine inhibits IL-1beta-induced NFkappaB activation in human
osteoarthritic chondrocytes. Osteoarthritis Cartilage. 11:290–298.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Nakamura M, Shibakawa A, Tanaka M, Kato T
and Nishioka K: Effects of glucosamine hydrochloride on the
production of prostaglandin E2, nitric oxide and metalloproteases
by chondrocytes and synoviocytes in osteoarthritis. Clin Exp
Rheumatol. 22:293–299. 2004.PubMed/NCBI
|
|
5.
|
Quastel JH and Cantero A: Inhibition of
tumor growth by D-glucosamine. Nature. 171:252–254. 1953.
View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Bekesi JG and Winzler RJ: Inhibitory
effects of D-glucosamine on the growth of Walker 256 carcinosarcoma
and on protein, RNA, and DNA synthesis. Cancer Res. 30:2905–2912.
1970.PubMed/NCBI
|
|
7.
|
Bosmann HB: Inhibition of protein,
glycoprotein, ribonucleic acid and deoxyribonucleic acid synthesis
by D-glucosamine and other sugars in mouse leukemic cells L5178Y
and selective inhibition in SV-3T3 compared with 3T3 cells. Biochim
Biophys Acta. 240:74–93. 1970. View Article : Google Scholar
|
|
8.
|
Wang Z, Liang R, Huang GS, Piao Y, Zhang
YQ, Wang AQ, Dong BX, Feng JL, Yang GR and Guo Y: Glucosamine
sulfate-induced apoptosis in chronic myelogenous leukemia K562
cells is associated with translocation of cathepsin D and
downregulation of Bcl-xL. Apoptosis. 11:1851–1860. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Oh HJ, Lee JS, Song DK, Shin DH, Jang BC,
Suh SI, Park JW, Suh MH and Baek WK: D-glucosamine inhibits
proliferation of human cancer cells through inhibition of p70S6K.
Biochem Biophys Res Commun. 360:840–845. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Chesnokov V, Sun C and Itakura K:
Glucosamine suppresses proliferation of human prostate carcinoma
DU145 cells through inhibition of STAT3 signaling. Cancer Cell Int.
9:252009. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Hwang MS and Baek WK: Glucosamine induces
autophagic cell death through the stimulation of ER stress in human
glioma cancer cells. Biochem Biophys Res Commun. 399:111–116. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Jung CW, Jo JR, Lee SH, Park YK, Jung NK,
Song DK, Bae J, Nam KY, Ha JS, Park IS, Park GY, Jang BC and Park
JW: Anti-cancer properties of glucosamine-hydrochloride in YD-8
human oral cancer cells: Induction of the caspase-dependent
apoptosis and down-regulation of HIF-1α. Toxicol In Vitro.
26:42–50. 2012.PubMed/NCBI
|
|
13.
|
Park JY, Park JW, Suh SI and Baek WK:
D-glucosamine down-regulates HIF-1alpha through inhibition of
protein translation in DU145 prostate cancer cells. Biochem Biophys
Res Commun. 382:96–101. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Wang GL, Jiang BH, Rue EA and Semenza GL:
Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS
heterodimer regulated by cellular O2 tension. Proc Natl
Acad Sci USA. 92:5510–5514. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Semenza GL: Hypoxia-inducible factor 1:
master regulator of O2 homeostasis. Curr Opin Genet Dev.
8:588–594. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Salceda S and Caro J: Hypoxia-inducible
factor 1 alpha (HIF-1alpha) protein is rapidly degraded by the
ubiquitin-proteasome system under normoxic conditions. Its
stabilization by hypoxia depends on redox-induced chages. J Biol
Chem. 272:22642–22647. 1997. View Article : Google Scholar
|
|
17.
|
Huang LE, Gu J, Schau M and Bunn HF:
Regulation of hypoxia-inducible factor1alpha is mediated by an
O2-dependent degradation domain via the ubiquitin
proteasome pathway. Proc Natl Acad Sci USA. 95:7987–7992. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Tanimoto K, Makino Y, Pereira T and
Poellinger L: Mechanism of regulation of the hypoxia-inducible
factor-1 alpha by the von Hippel-Lindau tumor suppressor protein.
EMBO J. 19:4298–4309. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Ivan M, Kondo K, Yang H, Kim W, Valiando
J, Ohh M, Salic A, Asara JM, Lane WS and Kaelin Jr WG: HIFalpha
targeted for VHL-mediated destruction by proline hydroxylation:
implications for O2 sensing. Science. 292:464–468. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Qian D, Lin HY, Wang HM, Zhang X, Liu DL,
Li QL and Zhu C: Normoxic induction of the hypoxic-inducible
factor-1 alpha by interleukin-1 beta involves the extracellular
signal-regulated kinase 1/2 pathway in normal human cytotrophoblast
cells. Biol Reprod. 70:1822–1827. 2004. View Article : Google Scholar
|
|
21.
|
Doronzo G, Russo I, Mattiello L, Riganti
C, Anfossi G and Trovati M: Insulin activates hypoxia-inducible
factor-1alpha in human and rat vascular smooth muscle cells via
phosphatidylinositol-3 kinase and mitogen-activated protein kinase
pathways: impairment in insulin resistance owing to defects in
insulin signaling. Diabetologia. 49:1049–1063. 2006. View Article : Google Scholar
|
|
22.
|
Shin HJ, Choi MS, Ryoo NH, Nam KY, Park
GY, Bae JH, Suh SI, Baek WK, Park JW and Jang BC:
Manganese-mediated upregulation of HIF-1alpha protein in Hep2 human
laryngeal epithelial cells via activation of the family of MAPKs.
Toxicol In Vitro. 24:1208–1214. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Leung KW, Ng HM, Tang MK, Wong CC, Wong RN
and Wong AS: Ginsenoside-Rg1 mediates a hypoxia-independent
upregulation of hypoxia-inducible factor-1α to promote
angiogenesis. Angiogenesis. 14:515–522. 2011.PubMed/NCBI
|
|
24.
|
Yen ML, Su JL, Chien CL, Tseng KW, Yang
CY, Chen WF, Chang CC and Kuo ML: Diosgenin induces
hypoxia-inducible factor-1 activation and angiogenesis through
estrogen receptor-related phosphatidylinositol 3-kinase/Akt and p38
mitogen-activated protein kinase pathways in osteoblasts. Mol
Pharmacol. 68:1061–1073. 2005. View Article : Google Scholar
|
|
25.
|
Jang BC: The fruit juice of Morinda
citrifolia (noni) down-regulates HIF-1α protein expression
through inhibition of PKB, ERK-1/2, JNK-1 and S6 in
manganese-stimulated A549 human lung cancer cells. Int J Mol Med.
29:499–504. 2012.
|
|
26.
|
Tamura K, Yoshie M, Miyajima E, Kano M and
Tachikawa E: Stathmin regulates hypoxia-inducible factor-1α
expression through the mammalian target of rapamycin pathway in
ovarian clear cell adenocarcinoma. ISRN Pharmacol.
30:2795932013.PubMed/NCBI
|
|
27.
|
Xie SR, Wang Y, Liu CW, Luo K and Cai YQ:
Liquiritigenin inhibits serum-induced HIF-1α and VEGF expression
via the AKT/mTOR-p70S6K signalling pathway in HeLa cells. Phytother
Res. 26:1133–1141. 2012.PubMed/NCBI
|
|
28.
|
Jeong JH, Jeong YJ, Cho HJ, Shin JM, Kang
JH, Park KK, Park YY, Chung IK, Chang HW and Magae J: Ascochlorin
inhibits growth factor-induced HIF-1α activation and
tumor-angiogenesis through the suppression of EGFR/ERK/p70S6K
signaling pathway in human cervical carcinoma cells. J Cell
Biochem. 113:1302–1313. 2012.PubMed/NCBI
|
|
29.
|
Laplante M and Sabatini DM: mTOR signaling
in growth control and disease. Cell. 149:274–293. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Epstein AC, Gleadle JM, McNeill LA,
Hewitson KS, O’Rourke J, Mole DR, Mukherji M, Metzen E, Wilson GD,
Dhanda A, Tian YM, Masson N, Hamilton DL, Jaakkola P, Barstead R,
Hodgkin J, Maxwell PH, Pugh CW, Schofield CJ and Ratcliffe PJ:
C. elegans EGL-9 and mammalian homologs define a family of
dioxygenases that regulate HIF by prolyl hydroxylation. Cell.
107:43–54. 2001. View Article : Google Scholar
|
|
31.
|
Maxwell PH, Wiesener MS, Chang GW,
Clifford SC, Vaux EC, Cockman ME, Wykoff CC, Pugh CW, Maher ER and
Ratcliffe PJ: The tumour suppressor protein VHL targets
hypoxia-inducible factors for oxygen-dependent proteolysis. Nature.
399:271–275. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Meyuhas O: Physiological roles of
ribosomal protein S6: one of its kind. Int Rev Cell Mol Biol.
268:1–37. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Berven LA and Crouch MF: Cellular function
of p70S6K: a role in regulating cell motility. Immunol Cell Biol.
78:447–451. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Fang CX, Yang X, Sreejayan N and Ren J:
Acetaldehyde promotes rapamycin-dependent activation of p70(S6K)
and glucose uptake despite inhibition of Akt and mTOR in
dopaminergic SH-SY5Y human neuroblastoma cells. Exp Neurol.
203:196–204. 2007. View Article : Google Scholar
|
|
35.
|
Baird TD and Wek RC: Eukaryotic initiation
factor 2 phosphorylation and translational control in metabolism.
Adv Nutr. 3:307–321. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36.
|
De Haro C, Méndez R and Santoyo J: The
eIF-2alpha kinases and the control of protein synthesis. FASEB J.
10:1378–1387. 1996.PubMed/NCBI
|
|
37.
|
Maynard MA and Ohh M: Von Hippel-Lindau
tumor suppressor protein and hypoxia-inducible factor in kidney
cancer. Am J Nephrol. 24:1–13. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
38.
|
Hubbi ME, Hu H, Kshitiz Ahmed I, Levchenko
A and Semenza GL: Chaperone-mediated autophagy targets
hypoxiainducible factor-1α (HIF-1α) for lysosomal degradation. J
Biol Chem. 288:10703–10714. 2013.
|
|
39.
|
Tesoriere G, Vento R and Calvaruso G:
Inhibitory effect of D-glucosamine on glycolysis in bovine retina.
Biochim Biophys Acta. 385:58–67. 1975. View Article : Google Scholar : PubMed/NCBI
|
|
40.
|
Zhang J, Zhao M and Peng S: Synthesis of
mimetic peptides containing glucosamine. Carbohydr Res.
346:1997–2003. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
41.
|
Oguchi M, Miyatake Y, Ayabe J and Akamatsu
N: Phosphorylation of D-glucosamine by rat liver glucokinase. J
Biochem. 77:1117–1121. 1975.PubMed/NCBI
|
|
42.
|
Uldry M, Ibberson M, Hosokawa M and
Thorens B: GLUT2 is a high affinity glucosamine transporter. FEBS
Lett. 524:199–203. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
43.
|
Kim YK, Park JH, Park SH, Lim B, Baek WK,
Suh SI, Lim JG, Ryu GR and Song DK: Protective role of
glucagon-like peptide-1 against glucosamine induced cytotoxicity in
pancreatic beta cells. Cell Physiol Biochem. 25:211–220. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
44.
|
Brennan PA, Mackenzie N and Quintero M:
Hypoxia-inducible factor 1alpha in oral cancer. J Oral Pathol Med.
34:385–389. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
45.
|
Song Y, Wang W, Qu X and Sun S: Effects of
hypoxia inducible factor-1 alpha (HIF-1alpha) on the growth and
adhesion in tongue squamous cell carcinoma cells. Indian J Med Res.
129:154–163. 2009.PubMed/NCBI
|
